Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000769149 | SCV000900523 | uncertain significance | Cardiomyopathy | 2017-08-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303237 | SCV004005972 | uncertain significance | Cardiovascular phenotype | 2023-05-05 | criteria provided, single submitter | clinical testing | The c.159C>T variant (also known as p.G53G), located in coding exon 2 of the TTN gene, results from a C to T substitution at nucleotide position 159. This nucleotide substitution does not change the glycine at codon 53. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |